Compare IOP Reduction

15 products »

close Created with Sketch.

Istalol

Bausch + Lomb Inc.

Istalol (timolol maleate ophthalmic solution) 0.5% is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma

At-a-Glance
  • Mechanism of Action: Timolol maleate is a beta1 and beta2 (non-selective) adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane-stabilizing) activity.
  • Dosage: The starting dose is one drop in the affected eye(s) once daily in the AM. If the patient's intraocular pressure is not at a satisfactory level on this regimen, concomitant therapy with other agent(s) for lowering intraocular pressure can be instituted. The concomitant use of two topical beta-adrenergic blocking agents is not recommended.

Details

FDA

Yes

CE Mark

Not specified

Active Ingredients

Timolol maleate

Application

Topical

Status

Prescription

Strength

0.5%

From Your Peers

Glaucoma Research Highlights

READ ARTICLE »

Show More

Company Information

Contact the company for additional information, availability, or pricing:

Bausch + Lomb Inc.

bausch.com

400 Somerset Corporate Blvd.

Bridgewater, NJ 08807